Document Preview Unavailable
Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Trial
You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library